Effects of Androgen Ablation Therapy in TRAIL Death Ligand and Its Receptors Expression in Advanced Prostate Cancer

Publisher： Karger

E-ISSN： 1423-0399|84|4|445-451

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.84, Iss.4, 2010-03, pp. : 445-451

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The predictive value of ERG protein expression for development of castration‐resistant prostate cancer in hormone‐naïve advanced prostate cancer treated with primary androgen deprivation therapy

By  

THE PROSTATE, Vol. 75, Iss. 14, 2015-10 ,pp. : 1499-1509

John Wiley & Sons Inc

Access to resources Recommend Favorite

Adverse effects of androgen‐deprivation therapy in prostate cancer and their management

By  

BJU INTERNATIONAL, Vol. 115, Iss. S5, 2015-04 ,pp. : 3-13

John Wiley & Sons Inc

Access to resources Recommend Favorite

Psychological effects of androgen‐deprivation therapy on men with prostate cancer and their partners

By  

CANCER, Vol. 121, Iss. 24, 2015-12 ,pp. : 4286-4299

John Wiley & Sons Inc

Access to resources Recommend Favorite

Intermittent Androgen Deprivation for Locally Advanced Prostate Cancer

By  

Oncology, Vol. 65, Iss. 1, 2003-09 ,pp. : 24-28

Karger

Access to resources Recommend Favorite

Concept and viability of androgen annihilation for advanced prostate cancer

By  

CANCER, Vol. 120, Iss. 17, 2014-09 ,pp. : 2628-2637

John Wiley & Sons Inc

Access to resources Recommend Favorite